Brookfield resumes Grifols takeover talks, El Confidencial reports

Important legal information about the email you will be sending. By using this service, you agree to input your real email address and only send it to people you know. It is a violation of law in some jurisdictions to falsely identify yourself in an email. All information you provide will be used by Fidelity solely for the purpose of sending the email on your behalf. The subject line of the email you send will be "Fidelity.com: "

Brookfield resumes Grifols takeover talks, El Confidencial reports

, Reuters - 2:54 AM ET 4/2/2025 mergers-and-acquisitions

MADRID, April 2 (Reuters) - Canadian investment fund Brookfield has resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols four months after a previous attempt fell through, news website El Confidencial reported on Wednesday, citing unidentified industry sources.

Brookfield has contacted the Grifols family and is considering making an offer valuing the company at 7 billion euros ($7.55 billion), El Confidencial said, adding that the investment fund is being advised by Morgan Stanley ( MS ).

A non-binding offer that valued Grifols at 6.7 billion euros was withdrawn by Brookfield in November after Grifols management rejected the bid as too low and recommended shareholders keep their shares.

The Grifols family declined to comment. Brookfield representatives and Morgan Stanley ( MS ) did not respond immediately to requests for comment. ($1 = 0.9266 euros) (Reporting by Inti Landauro and Andres Gonzalez Editing by David Goodman)

(c) Reuters 2025. All rights reserved. Republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks and trademarks of the Reuters group of companies around the world.